Tonix Pharmaceuticals Holding Corp (TNXP)
0.14
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.1404
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Total Assets (Quarterly): 70.31M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 70.31M |
| March 31, 2024 | 135.34M |
| December 31, 2023 | 154.46M |
| September 30, 2023 | 139.28M |
| June 30, 2023 | 159.74M |
| March 31, 2023 | 179.09M |
| December 31, 2022 | 225.69M |
| September 30, 2022 | 242.65M |
| June 30, 2022 | 276.16M |
| March 31, 2022 | 223.72M |
| December 31, 2021 | 240.90M |
| September 30, 2021 | 214.77M |
| June 30, 2021 | 189.16M |
| March 31, 2021 | 183.52M |
| December 31, 2020 | 98.18M |
| September 30, 2020 | 67.62M |
| June 30, 2020 | 58.34M |
| March 31, 2020 | 33.93M |
| December 31, 2019 | 14.56M |
| September 30, 2019 | 12.27M |
| June 30, 2019 | 15.01M |
| March 31, 2019 | 20.02M |
| December 31, 2018 | 26.32M |
| September 30, 2018 | 16.06M |
| June 30, 2018 | 18.36M |
| Date | Value |
|---|---|
| March 31, 2018 | 20.98M |
| December 31, 2017 | 26.75M |
| September 30, 2017 | 30.54M |
| June 30, 2017 | 35.82M |
| March 31, 2017 | 23.78M |
| December 31, 2016 | 27.51M |
| September 30, 2016 | 29.80M |
| June 30, 2016 | 34.32M |
| March 31, 2016 | 31.35M |
| December 31, 2015 | 47.02M |
| September 30, 2015 | 57.82M |
| June 30, 2015 | 50.93M |
| March 31, 2015 | 60.47M |
| December 31, 2014 | 39.54M |
| September 30, 2014 | 47.33M |
| June 30, 2014 | 45.06M |
| March 31, 2014 | 50.20M |
| December 31, 2013 | 8.736M |
| September 30, 2013 | 7.570M |
| June 30, 2013 | 0.3144M |
| March 31, 2013 | 0.5945M |
| December 31, 2012 | 2.117M |
| September 30, 2012 | 0.19M |
| June 30, 2012 | 1.526M |
| March 31, 2012 | 2.649M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.56M
Minimum
Dec 2019
276.16M
Maximum
Jun 2022
153.02M
Average
159.74M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 1.514B |
| Geovax Labs Inc | 4.095M |
| Abbott Laboratories | 74.36B |
| SIGA Technologies Inc | 192.66M |
| Chimerix Inc | 178.51M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.20M |
| Shareholders Equity (Quarterly) | 42.10M |
| Debt to Equity Ratio | 0.2016 |
| Current Ratio | 1.147 |
| Net Debt Paydown Yield | -9.21% |